Fibrinogen-depleted human platelet lysate (Cambium Bio)

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameFibrinogen-depleted human platelet lysate (Cambium Bio)
Drug Alias NameElate OcularFD-hPLAurarixCAM-101
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Platelet therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsGraft vs Host DiseaseDry Eye SyndromesXerophthalmia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesCambium Bio Ltd
Inactive CompaniesCambium Medical Technologies Llc
Active IndicationsDry Eye SyndromesXerophthalmia
Inactive IndicationsGraft vs Host DiseaseEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A